Siret Ratip on Muck Rack

Siret Ratip

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Siret

Contact Siret, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study

|
By Simon Renders, Maud Ngoya, Laurence de Leval, Rachael Pocock, Ron Ram, Tobias Gedde-Dahl, Yasmina Serroukh, Gesine Bug, Nicolaus Kröger, Arnon Nagler, Thomas Pabst, Werner Rabitsch, Ibrahim Yakoub-Agha, Matthias Eder, Siret Ratip, Christoph Scheid, José Antonio Pérez-Simón, Eva Wagner-Drouet, Anna Sureda, Norbert Schmitz, Bertram Glass, Ali Bazarbachi, Peter Dreger, Herve Finel, Irma Khvedelidze
| Nature Verified
Abstract To the Editor T-cell/histiocyte-rich LBCL (THRLBCL) is an uncommon entity within the large B-cell lymphoma family, comprising less than 5% of all LBCL [1]. Compared to other LBCL, THRLBCL patients are younger, commonly male, present with higher International Prognostic Indexes (IPI), and advanced disease stages [2]. THRLBCL is named for its unique immunomodulating micro-milieu characterized by T-cell and histiocyte infiltration.
Open in Who Shared Issue with article?

Incidence and outcome of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working party of EBMT

|
By Simone Cesaro, Chiara Garonzi, Gloria Tridello, Inge Verheggen, Daihong Liu, Catherine Flynn, Ali Alahmari, Leylagül Kaynar, Werner Rabitsch, Vedat Uygun, Pedro Chorão, Jiong Hu, Albert Esquirol, José Luis Piñana, Mahmoud Aljurf, Eva Wagner-Drouet, Peter Lang, Guillermo Martín-Sánchez, Barbara Nasilowska-Adamska, Jan Styczynski, Ron Ram, Elisabetta Metafuni, Alina Doina Tanase, Krzysztof Kalwak, Bianca Serio, Hasan Hashem, Luca Castagna, Marta González Vicent, Musa Karakukcu, Ioannis Baltadakis, Edoardo Benedetti, Malgorzata Mikulska, Rafael de la Camara, Dina Averbuch, Siret Ratip, Luca Facchini, Khaled Halahleh
| Nature Verified
Hemorrhagic cystitis (HC) is a frequent complication after hematopoietic cell transplant (HCT), with an incidence ranging from 2 to 66% depending on the type of transplant and the age of the patient [1,2]. In the last two decades, the use of post-transplant cyclophosphamide (PT-Cy) as graft-versus-host-disease (GVHD) prophylaxis has been associated with an increased incidence of HC [3,4].
Open in Who Shared Issue with article?
See all 2 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified